ABAnthony Bateman

Anthony Bateman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anthony Bateman has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Can All Oxygen Molecules Accumulate in One Corner of the Room? Treating Pathological Narcissism Requires High Standard Randomized Clinical Trials. A Commentary on the Trial by Mohajerin et al.

    by Giancarlo Dimaggio, Felix Inchausti, Anthony Bateman, Sune Bo, Lois Choi‐Kain, Majse Lind, Patrick Luyten, Angus MacBeth, Sophie Juul, David Kealy, et al.

    Narcissistic personality disorder (NPD) and pathological narcissism (PN) urgently need empirically supported treatment options. Mohajerin et al. randomized controlled trial yielded promise in addressing this gap. However, in this commentary, an international group of personality disorder experts identify a number of issues with the trial methodology, reporting and interpretation: (i) the unlikeliness that consecutive sample recruitment would result in almost equal number of participants in grandiose vs. vulnerable subgroups; (ii) the unlikeliness that consecutive sample recruitment would result in almost equal number of participating men and women; (iii) the unlikely possibility that grandiose and vulnerable narcissism would appear as uncorrelated subtypes; (iv) dissimilar treatment responses to schema‐focused therapy vs. Unified Protocol; (v) absence of dropouts; (vi) unclear randomization procedure; (vii) poor screening and recruitment procedures and limited transparency in trial registration; (viii) exclusive reliance on self‐report measures; (ix) limited transparency in supervision and treatment fidelity procedures; (x) nonequivalence of treatment dose and duration; and (xi) lack of clarity on how the disclosure of NPD diagnosis to participants was handled in the trial. In light of these concerns, it is difficult to reconcile the results of this trial with the inherent challenges of treating NPD and PN. We therefore warrant against considering it a benchmark in NPD treatment innovation.


  • Mentalization-based-treatment techniques across psychodynamic, cognitive and MBT therapies

    by Antonello Colli, Salvatore Gullo, Giulia Gagliardini, Guia Pandolfi, Anthony Bateman, Peter Fonagy

    This study examined whether therapists from orientations that do not explicitly target mentalizing-namely psychodynamic therapy (PDT) and cognitive behavioural therapy (CBT)-use interventions consistent with Mentalization-Based Treatment (MBT), and how their use compares with MBT-oriented therapy. Seventy-five verbatim transcripts were randomly selected from audio-recorded psychotherapy sessions involving patients with personality disorders or subclinical personality difficulties. Therapist orientation was determined by self-identification (MBT = 25, CBT = 25, PDT = 25). Sessions were independently rated using the MBT Adherence and Competence Scale (MBT-ACS) and the Reflective Functioning (RF) Scale. MBT-consistent techniques were observed in PDT and CBT sessions, though at lower levels than in MBT. MBT therapists showed higher MBT-ACS scores, particularly in maintaining a not-knowing stance and identifying non-mentalizing modes. Across orientations, higher MBT-ACS scores were associated with lower mean session-level RF, but also with greater within-session RF increases. Mentalizing-oriented techniques appear across therapeutic orientations and may represent trans-theoretical process elements. Their association with both lower average RF and greater within-session change suggests they may be more frequently used in clinically challenging moments, supporting the restoration or enhancement of mentalizing.

  • Open Access

    Assessing mentalization in practice: Reliability of the mentalization‐based treatment research adherence and competence scale

    by Karen Yirmiya, Sophie Marjoribanks, Peter Fonagy, Anthony Bateman

    Objectives: Mentalization‐Based Treatment (MBT) requires rigorous fidelity assessment to ensure accurate delivery and validate treatment efficacy. This study introduces the Mentalization‐Based Treatment Research Adherence and Competence Scale (MBT‐RACS), a new instrument developed initially for research purposes to align with contemporary MBT principles and address psychometric and conceptual limitations found in earlier adherence assessment approaches. Methods: Inter‐rater reliability of the MBT‐RACS was evaluated using 126 recorded MBT sessions (104 group, 22 individual), rated by 17 trained coders. Results: The results indicated strong overall reliability, with most domains demonstrating good to excellent inter‐rater agreement across both group and individual sessions, irrespective of ratings from two or three raters. Total adherence intraclass correlation coefficients (ICCs) were notably high for both group (.84) and individual (.95) sessions rated by two coders, substantially exceeding the reliability typically reported for comparable adherence instruments. Conclusions: These findings suggest that the MBT‐RACS's format, which emphasizes broader, clinically meaningful domains, may contribute to improved consistency in ratings. The scale's robust reliability supports its applicability in research and clinical supervision, enhancing methodological rigour, quality assurance and targeted feedback for effective MBT training and implementation.


  • Open Access

    Childhood maltreatment, dissociation and borderline personality disorder: Preliminary data on the mediational role of mentalizing in complex post‐traumatic stress disorder

    by Anthony Bateman, Eva Rüfenacht, Nader Perroud, Martin Debbané, Tobias Nolte, Lisa Shaverin, Peter Fonagy

    Objectives: Treatments for borderline personality disorder (BPD) and post‐traumatic stress disorder (PTSD) are less effective for patients with co‐occurring symptoms of both disorders, who are considered to have complex PTSD (cPTSD), compared with patients with either condition alone. Evidence suggests that co‐occurrence of symptoms indicates greater impairment in mentalizing. This study examines evidence for targeting mentalizing when treating individuals with co‐occurring symptoms, irrespective of their exposure to developmental trauma and, for the first time, investigates the mediational role of mentalizing in the associations between BPD symptomatology and cPTSD. Design: We identified in a routine clinical service a group of patients with BPD, with or without co‐occurring symptoms of PTSD. We hypothesized that patients with co‐occurring symptoms and a history of childhood maltreatment will show more severe clinical profiles and greater mentalizing problems, which in turn lead to symptoms consistent with cPTSD. Method: Clinical profiles of 72 patients with BPD (43 with and 29 without co‐occurring symptoms of PTSD; mean age in both groups 28 years, 79% and 83% female, respectively) were identified using the Structured Clinical Interview for DSM‐IV Axis II Disorders. Patients completed self‐report measures of BPD and PTSD symptoms, well‐being, dissociation and reflective functioning. Childhood trauma histories were evaluated. Results: Compared with patients with BPD‐only, those with co‐occurring BPD and PTSD showed greater severity in terms of BPD and dissociative symptoms, met a broader range of BPD diagnostic criteria, had a greater sense of personal worthlessness and self‐evaluated their well‐being as considerably diminished. This group was also more inclined to recall increased instances of childhood sexual abuse. In a mediation analysis, mentalizing acted as a partial mediator for the relationship between BPD severity and cPTSD, as well as between dissociative symptoms and cPTSD. Interestingly, mentalizing did not mediate the relationship between childhood sexual abuse and cPTSD. Conclusions: Overall, the correlational findings are consistent with an intended focus on mentalizing to treat cPTSD symptoms in individuals who also meet criteria for a diagnosis of BPD.


  • Mentalizing mediates the relationship between psychopathy and premeditated criminal offending in schizophrenia: a 6-year follow-up study

    by Sune Bo, Carla Sharp, Majse Lind, Sebastian Simonsen, Anthony Bateman

    Research has shown that schizophrenia augments the risk for criminal behaviour and variables both defining- and related to schizophrenia, increase criminal offending. Premeditated criminal offendin...


  • Mentalizing and Group Psychotherapy: A Novel Treatment for Antisocial Personality Disorder

    by Anthony W. Bateman

    Antisocial personality disorder (ASPD) is a common condition associated with interpersonal and social violence, and current treatments are unsatisfactory. Mentalizing, which has developmental roots...


  • Mentalizing in Psychiatric Practice

    by Anthony W. Bateman, Rachel Gibbons, Jo O'Reilly

    Seminars in the Psychotherapies - June 2021

  • Rupture and Repair in Mentalization-Based Group Psychotherapy

    by Anthony Bateman, Chloe Campbell, Peter Fonagy

    The article explores ideas about the role of group mentalizing—the experience of joint attention and shared intentionality—as a process that can support the emergence of more collaborative and salutogenic social functioning. This is based on developmental and evolutionary thinking about the importance of joint attention in human social cognitive development and functioning. The importance of experiencing rupture and repair as part of the process of thinking together—while also working with the separate nature of our thoughts—is described, emphasizing that it is through an understanding of the complex and inevitably uneven and challenging nature of joint attention and social cooperation that such cooperation is itself made possible.


  • Open Access

    Mentalization for Offending Adult Males (MOAM): study protocol for a randomized controlled trial to evaluate mentalization-based treatment for antisocial personality disorder in male offenders on community probation

    by Peter Fonagy, Jessica Yakeley, Tessa Gardner, Elizabeth Simes, Mary McMurran, Paul Moran, Mike Crawford, Alison Frater, Barbara Barrett, Angus Cameron, et al.

    Background: Antisocial personality disorder (ASPD), although associated with very significant health and social burden, is an under-researched mental disorder for which clinically effective and cost-effective treatment methods are urgently needed. No intervention has been established for prevention or as the treatment of choice for this disorder. Mentalization-based treatment (MBT) is a psychotherapeutic treatment that has shown some promising preliminary results for reducing personality disorder symptomatology by specifically targeting the ability to recognize and understand the mental states of oneself and others, an ability that is compromised in people with ASPD. This paper describes the protocol of a multi-site RCT designed to test the effectiveness and cost-effectiveness of MBT for reducing aggression and alleviating the wider symptoms of ASPD in male offenders subject to probation supervision who fulfil diagnostic criteria for ASPD. Methods: Three hundred and two participants recruited from a pool of offenders subject to statutory supervision by the National Probation Service at 13 sites across the UK will be randomized on a 1:1 basis to 12 months of probation plus MBT or standard probation as usual, with follow-up to 24 months post-randomization. The primary outcome is frequency of aggressive antisocial behaviour as assessed by the Overt Aggression Scale – Modified. Secondary outcomes include violence, offending rates, alcohol use, drug use, mental health status, quality of life, and total service use costs. Data will be gathered from police and criminal justice databases, NHS record linkage, and interviews and self-report measures administered to participants. Primary analysis will be on an intent-to-treat basis; per-protocol analysis will be undertaken as secondary analysis. The primary outcome will be analysed using hierarchical mixed-effects linear regression. Secondary outcomes will be analysed using mixed-effects linear regression, mixed-effects logistic regression, and mixed-effects Poisson models for secondary outcomes depending on whether the outcome is continuous, binary, or count data. A cost-effectiveness and cost-utility analysis will be undertaken. Discussion: This definitive, national, multi-site trial is of sufficient size to evaluate MBT to inform policymakers, service commissioners, clinicians, and service users about its potential to treat offenders with ASPD and the likely impact on the population at risk. Trial registration: ISRCTN 32309003. Registered on 8 April 2016.


  • Open Access

    Individual participant data systematic reviews with meta-analyses of psychotherapies for borderline personality disorder: A protocol

    by Ole Jakob Storebø, Johanne Pereira Ribeiro, Mickey T. Kongerslev, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, Klaus Lieb, Anthony Bateman, Richard Kirubakaran, Nicolas Dérian, Eirini Karyotaki, et al.

    Introduction The heterogeneity in people with BPD and the range of specialised psychotherapies means that people with certain BPD characteristics might benefit more or less from different types of psychotherapy. Identifying moderating characteristics of individuals is a key to refine and tailor standard treatments so they match the specificities of the individual patient. The objective of this is to improve the quality of care and the individual outcomes. Thus, the aim of the current reviews is to investigate potential predictors and moderating patient characteristics on treatment outcomes for patients with BPD. Methods and analysis Our primary meta-analytic method will be the one-stage random-effects approach. To identify predictors, we will be using the one-stage model that accounts for interaction between covariates and treatment allocation. Heterogeneity in case-mix will be assessed using a membership model based on a multinomial logistic regression where study membership is the outcome. A random-effects meta-analysis is chosen to account for expected levels of heterogeneity. Ethics and dissemination The statistical analyses will be conducted on anonymised data that have already been approved by the respective ethical committees that originally assessed the included trials. The three IPD reviews will be published in high impact factor journals and their results will be presented at international conferences and national seminars. Protocol registration The IPD reviews, described in this study protocol, are registered with the PROSPERO International Prospective Register of Systematic Reviews (registration number: awaiting) Strengths and limitations of this protocol These IPD-reviews are the first to systematically review and investigate psychotherapy for people with borderline personality disorder using individual participant data. The IPD-reviews will provide information on moderators and predictors in patients with borderline personality disorder that predict who may benefit most from which type of specialised psychotherapy. Individual participant data allows for a more precise risk of bias assessment and decreases the amount of unclear risk of bias in many of the included trials. A limitation to IPD-reviews in general is that data retrieval can be challenging. The IPD-reviews are limited to the outcomes and patient characteristics that have been assessed in the included trials.